Ignite Creation Date:
2025-12-25 @ 3:49 AM
Ignite Modification Date:
2026-03-13 @ 5:07 PM
Study NCT ID:
NCT06439602
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-15
First Post:
2024-05-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)
Sponsor:
Arthrosi Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AR882-302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None